Kunal Mahajan: Lipoprotein(a) and LDL-C Target Attainment in ACS Patients
Kunal Mahajan, Director and Chief Interventional Cardiologist at Himachal Heart Institute, shared a post on X about a recent article he and his colleagues co-authored, adding:
“Happy to share our study in the Journal of Clinical Lipidology.
In ACS patients treated with triple oral lipid-lowering therapy, lipoprotein(a) increased significantly after ACS, and higher baseline lipoprotein(a) predicted failure to achieve low-density lipoprotein cholesterol less than fifty milligrams per deciliter at one month.”
Title: Changes in Lipoprotein(a) and Their Association With LDL-C in ACS Patients Treated with Triple Oral Lipid-Lowering Therapy
Authors: Kunal Mahajan, Nitin Mahajan, Jai Bharat Sharma, Surender Himral, Tanuj Bhatia, Deep Dutta
Read the Full Article on Journal of Clinical Lipidology
Stay updated on all scientific advances with Hemostasis Today.
-
May 1, 2026, 17:55Salih Ehsan: The Deceptive Nature of B12 Deficiency Not Just Anemia
-
May 1, 2026, 17:45Angela Blue: Insurance Education as a Tool for Strengthening Patient Communities
-
May 1, 2026, 17:36Smitirupa Mishra: Hematology Formulas Made Simple, Structured, And Useful For Everyday Clinical Practice
-
May 1, 2026, 17:00Frank Weinz: VTE Prevention Strategies and Advances in Clinical Practice
-
May 1, 2026, 16:54Pierre François Sabouret: Women’s Health Should Be a Priority for All HCPs, Not Just WIC
-
May 1, 2026, 16:44Jean Jacques Kiladjian: A Global Triumph in MPN Research at ESHMPN 2026
-
May 1, 2026, 16:36Shek Sady Khan: VTE as a Major Yet Underrecognized Cause of Preventable Morbidity and Mortality
-
May 1, 2026, 16:11Anu Thomas: History of Blood Transfusion
-
May 1, 2026, 16:01A 100-Study Systematic Review Reevaluates PT and aPTT Testing in Perioperative Bleeding – JTH